June 22, 2016
On Tuesday, June 21, The University of Kansas Cancer Center teamed up with Children’s Mercy Hospital to co-host a Twitter chat about human papillomavirus (HPV), HPV-associated cancers and cancer prevention through vaccination.
During the lively discussion, questions were asked that addressed HPV-associated cancers, screening tests for these cancers, when children should receive the vaccination, common misperceptions about the HPV vaccination, what providers can do to ease concerns about the vaccination, Kansas and Missouri’s low HPV vaccination rates and how they can be improved, and new data supporting a two-dose schedule for children immunized before age 14.
The chat was moderated by physicians from The University of Kansas Cancer Center, The University of Kansas Hospital and Children’s Mercy Hospital. Our team of experts included:
- Dr. Roy Jensen, director of The University of Kansas Cancer Center
- Dr. Terance Tsue, physician-in-chief of The University of Kansas Cancer Center
- Dr. Stephen Lauer, pediatrician with The University of Kansas Hospital
- Dr. Belinda Vail, family medicine physician with The University of Kansas Hospital
- Dr. Kevin Ault, gynecologist with The University of Kansas Hospital
Thank you to the 67 Twitter users who participated in the hour-long discussion, sharing nearly 400 informative and original tweets, retweets and questions. With our participant’s help, we were able to garner almost 3 million impressions during the one-hour discussion, which resulted in #HPVchat trending nationally on Twitter.
Influential participants who were able to join the #HPVchat included the National Cancer Institute Cancer Control, CDC’s Division of Cancer Prevention and Control, Prevent Cancer Foundation and CDC’s Immunization Learn.
In total, 203 Twitter users used the hashtag (#HPVchat) in more than 800 tweets throughout June to help us spread awareness and education to more than 5.5 million people.
- Letter to the Community: It Prevents Cancer. What's the Problem?
By: Dr. Roy Jensen, director and Dr. Terry Tsue, physician-in-chief of The University of Kansas Cancer Center
- NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer
On January 27, 2016, the NCI-Designated Cancer Centers issued a consensus statement on the HPV vaccination in the United States